Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
UCLB Spinout Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $150 million Series C financing.
Novel method of analysis of stroke data
Latest news and highlights
Bringing innovation to life